Global NSCLS Drugs Market Report 2020 by Key Players, Types, Applications, Countries, Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
- MAI4281908
- 122 Pages
- April 2021
- BFSI
Under COVID-19 Outbreak, how the NSCLS Drugs Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global NSCLS Drugs market covered in Chapter 4:
Pfizer
Celgene
Genentech
Boehringer Ingelheim
QIAGEN NV
AstraZeneca
Roche
Eli Lilly and Company
OSI Pharmaceuticals
Novartis
In Chapter 11 and 13.3, on the basis of types, the NSCLS Drugs market from 2015 to 2026 is primarily split into:
Erlotinib (Tarceva and others)
Afatinib (Gilotrif)
Gefitinib (Iressa)
Bevacizumab (Avastin)
Crizotinib (Xalkori)
Ceritinib (Zykadia)
Others
In Chapter 12 and 13.4, on the basis of applications, the NSCLS Drugs market from 2015 to 2026 covers:
Squamous Cell Carcinoma
Large Cell Carcinoma
Adenocarcinoma
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global NSCLS Drugs Market Share by Type (2020-2026)
1.5.2 Erlotinib (Tarceva and others)
1.5.3 Afatinib (Gilotrif)
1.5.4 Gefitinib (Iressa)
1.5.5 Bevacizumab (Avastin)
1.5.6 Crizotinib (Xalkori)
1.5.7 Ceritinib (Zykadia)
1.5.8 Others
1.6 Market by Application
1.6.1 Global NSCLS Drugs Market Share by Application (2020-2026)
1.6.2 Squamous Cell Carcinoma
1.6.3 Large Cell Carcinoma
1.6.4 Adenocarcinoma
1.7 NSCLS Drugs Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on NSCLS Drugs Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of NSCLS Drugs Market
3.1 Value Chain Status
3.2 NSCLS Drugs Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of NSCLS Drugs
3.2.3 Labor Cost of NSCLS Drugs
3.2.3.1 Labor Cost of NSCLS Drugs Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Pfizer
4.1.1 Pfizer Basic Information
4.1.2 NSCLS Drugs Product Profiles, Application and Specification
4.1.3 Pfizer NSCLS Drugs Market Performance (2015-2020)
4.1.4 Pfizer Business Overview
4.2 Celgene
4.2.1 Celgene Basic Information
4.2.2 NSCLS Drugs Product Profiles, Application and Specification
4.2.3 Celgene NSCLS Drugs Market Performance (2015-2020)
4.2.4 Celgene Business Overview
4.3 Genentech
4.3.1 Genentech Basic Information
4.3.2 NSCLS Drugs Product Profiles, Application and Specification
4.3.3 Genentech NSCLS Drugs Market Performance (2015-2020)
4.3.4 Genentech Business Overview
4.4 Boehringer Ingelheim
4.4.1 Boehringer Ingelheim Basic Information
4.4.2 NSCLS Drugs Product Profiles, Application and Specification
4.4.3 Boehringer Ingelheim NSCLS Drugs Market Performance (2015-2020)
4.4.4 Boehringer Ingelheim Business Overview
4.5 QIAGEN NV
4.5.1 QIAGEN NV Basic Information
4.5.2 NSCLS Drugs Product Profiles, Application and Specification
4.5.3 QIAGEN NV NSCLS Drugs Market Performance (2015-2020)
4.5.4 QIAGEN NV Business Overview
4.6 AstraZeneca
4.6.1 AstraZeneca Basic Information
4.6.2 NSCLS Drugs Product Profiles, Application and Specification
4.6.3 AstraZeneca NSCLS Drugs Market Performance (2015-2020)
4.6.4 AstraZeneca Business Overview
4.7 Roche
4.7.1 Roche Basic Information
4.7.2 NSCLS Drugs Product Profiles, Application and Specification
4.7.3 Roche NSCLS Drugs Market Performance (2015-2020)
4.7.4 Roche Business Overview
4.8 Eli Lilly and Company
4.8.1 Eli Lilly and Company Basic Information
4.8.2 NSCLS Drugs Product Profiles, Application and Specification
4.8.3 Eli Lilly and Company NSCLS Drugs Market Performance (2015-2020)
4.8.4 Eli Lilly and Company Business Overview
4.9 OSI Pharmaceuticals
4.9.1 OSI Pharmaceuticals Basic Information
4.9.2 NSCLS Drugs Product Profiles, Application and Specification
4.9.3 OSI Pharmaceuticals NSCLS Drugs Market Performance (2015-2020)
4.9.4 OSI Pharmaceuticals Business Overview
4.10 Novartis
4.10.1 Novartis Basic Information
4.10.2 NSCLS Drugs Product Profiles, Application and Specification
4.10.3 Novartis NSCLS Drugs Market Performance (2015-2020)
4.10.4 Novartis Business Overview
5 Global NSCLS Drugs Market Analysis by Regions
5.1 Global NSCLS Drugs Sales, Revenue and Market Share by Regions
5.1.1 Global NSCLS Drugs Sales by Regions (2015-2020)
5.1.2 Global NSCLS Drugs Revenue by Regions (2015-2020)
5.2 North America NSCLS Drugs Sales and Growth Rate (2015-2020)
5.3 Europe NSCLS Drugs Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific NSCLS Drugs Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa NSCLS Drugs Sales and Growth Rate (2015-2020)
5.6 South America NSCLS Drugs Sales and Growth Rate (2015-2020)
6 North America NSCLS Drugs Market Analysis by Countries
6.1 North America NSCLS Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America NSCLS Drugs Sales by Countries (2015-2020)
6.1.2 North America NSCLS Drugs Revenue by Countries (2015-2020)
6.1.3 North America NSCLS Drugs Market Under COVID-19
6.2 United States NSCLS Drugs Sales and Growth Rate (2015-2020)
6.2.1 United States NSCLS Drugs Market Under COVID-19
6.3 Canada NSCLS Drugs Sales and Growth Rate (2015-2020)
6.4 Mexico NSCLS Drugs Sales and Growth Rate (2015-2020)
7 Europe NSCLS Drugs Market Analysis by Countries
7.1 Europe NSCLS Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe NSCLS Drugs Sales by Countries (2015-2020)
7.1.2 Europe NSCLS Drugs Revenue by Countries (2015-2020)
7.1.3 Europe NSCLS Drugs Market Under COVID-19
7.2 Germany NSCLS Drugs Sales and Growth Rate (2015-2020)
7.2.1 Germany NSCLS Drugs Market Under COVID-19
7.3 UK NSCLS Drugs Sales and Growth Rate (2015-2020)
7.3.1 UK NSCLS Drugs Market Under COVID-19
7.4 France NSCLS Drugs Sales and Growth Rate (2015-2020)
7.4.1 France NSCLS Drugs Market Under COVID-19
7.5 Italy NSCLS Drugs Sales and Growth Rate (2015-2020)
7.5.1 Italy NSCLS Drugs Market Under COVID-19
7.6 Spain NSCLS Drugs Sales and Growth Rate (2015-2020)
7.6.1 Spain NSCLS Drugs Market Under COVID-19
7.7 Russia NSCLS Drugs Sales and Growth Rate (2015-2020)
7.7.1 Russia NSCLS Drugs Market Under COVID-19
8 Asia-Pacific NSCLS Drugs Market Analysis by Countries
8.1 Asia-Pacific NSCLS Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific NSCLS Drugs Sales by Countries (2015-2020)
8.1.2 Asia-Pacific NSCLS Drugs Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific NSCLS Drugs Market Under COVID-19
8.2 China NSCLS Drugs Sales and Growth Rate (2015-2020)
8.2.1 China NSCLS Drugs Market Under COVID-19
8.3 Japan NSCLS Drugs Sales and Growth Rate (2015-2020)
8.3.1 Japan NSCLS Drugs Market Under COVID-19
8.4 South Korea NSCLS Drugs Sales and Growth Rate (2015-2020)
8.4.1 South Korea NSCLS Drugs Market Under COVID-19
8.5 Australia NSCLS Drugs Sales and Growth Rate (2015-2020)
8.6 India NSCLS Drugs Sales and Growth Rate (2015-2020)
8.6.1 India NSCLS Drugs Market Under COVID-19
8.7 Southeast Asia NSCLS Drugs Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia NSCLS Drugs Market Under COVID-19
9 Middle East and Africa NSCLS Drugs Market Analysis by Countries
9.1 Middle East and Africa NSCLS Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa NSCLS Drugs Sales by Countries (2015-2020)
9.1.2 Middle East and Africa NSCLS Drugs Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa NSCLS Drugs Market Under COVID-19
9.2 Saudi Arabia NSCLS Drugs Sales and Growth Rate (2015-2020)
9.3 UAE NSCLS Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt NSCLS Drugs Sales and Growth Rate (2015-2020)
9.5 Nigeria NSCLS Drugs Sales and Growth Rate (2015-2020)
9.6 South Africa NSCLS Drugs Sales and Growth Rate (2015-2020)
10 South America NSCLS Drugs Market Analysis by Countries
10.1 South America NSCLS Drugs Sales, Revenue and Market Share by Countries
10.1.1 South America NSCLS Drugs Sales by Countries (2015-2020)
10.1.2 South America NSCLS Drugs Revenue by Countries (2015-2020)
10.1.3 South America NSCLS Drugs Market Under COVID-19
10.2 Brazil NSCLS Drugs Sales and Growth Rate (2015-2020)
10.2.1 Brazil NSCLS Drugs Market Under COVID-19
10.3 Argentina NSCLS Drugs Sales and Growth Rate (2015-2020)
10.4 Columbia NSCLS Drugs Sales and Growth Rate (2015-2020)
10.5 Chile NSCLS Drugs Sales and Growth Rate (2015-2020)
11 Global NSCLS Drugs Market Segment by Types
11.1 Global NSCLS Drugs Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global NSCLS Drugs Sales and Market Share by Types (2015-2020)
11.1.2 Global NSCLS Drugs Revenue and Market Share by Types (2015-2020)
11.2 Erlotinib (Tarceva and others) Sales and Price (2015-2020)
11.3 Afatinib (Gilotrif) Sales and Price (2015-2020)
11.4 Gefitinib (Iressa) Sales and Price (2015-2020)
11.5 Bevacizumab (Avastin) Sales and Price (2015-2020)
11.6 Crizotinib (Xalkori) Sales and Price (2015-2020)
11.7 Ceritinib (Zykadia) Sales and Price (2015-2020)
11.8 Others Sales and Price (2015-2020)
12 Global NSCLS Drugs Market Segment by Applications
12.1 Global NSCLS Drugs Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global NSCLS Drugs Sales and Market Share by Applications (2015-2020)
12.1.2 Global NSCLS Drugs Revenue and Market Share by Applications (2015-2020)
12.2 Squamous Cell Carcinoma Sales, Revenue and Growth Rate (2015-2020)
12.3 Large Cell Carcinoma Sales, Revenue and Growth Rate (2015-2020)
12.4 Adenocarcinoma Sales, Revenue and Growth Rate (2015-2020)
13 NSCLS Drugs Market Forecast by Regions (2020-2026)
13.1 Global NSCLS Drugs Sales, Revenue and Growth Rate (2020-2026)
13.2 NSCLS Drugs Market Forecast by Regions (2020-2026)
13.2.1 North America NSCLS Drugs Market Forecast (2020-2026)
13.2.2 Europe NSCLS Drugs Market Forecast (2020-2026)
13.2.3 Asia-Pacific NSCLS Drugs Market Forecast (2020-2026)
13.2.4 Middle East and Africa NSCLS Drugs Market Forecast (2020-2026)
13.2.5 South America NSCLS Drugs Market Forecast (2020-2026)
13.3 NSCLS Drugs Market Forecast by Types (2020-2026)
13.4 NSCLS Drugs Market Forecast by Applications (2020-2026)
13.5 NSCLS Drugs Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global NSCLS Drugs Market Size Growth Rate by Type (2020-2026)
Figure Global NSCLS Drugs Market Share by Type in 2019 & 2026
Figure Erlotinib (Tarceva and others) Features
Figure Afatinib (Gilotrif) Features
Figure Gefitinib (Iressa) Features
Figure Bevacizumab (Avastin) Features
Figure Crizotinib (Xalkori) Features
Figure Ceritinib (Zykadia) Features
Figure Others Features
Table Global NSCLS Drugs Market Size Growth by Application (2020-2026)
Figure Global NSCLS Drugs Market Share by Application in 2019 & 2026
Figure Squamous Cell Carcinoma Description
Figure Large Cell Carcinoma Description
Figure Adenocarcinoma Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on NSCLS Drugs Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global NSCLS Drugs Market Size and Growth Rate 2015-2026
Table Industry News
Table Industry Policies
Figure Value Chain Status of NSCLS Drugs
Figure Production Process of NSCLS Drugs
Figure Manufacturing Cost Structure of NSCLS Drugs
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Pfizer Profile
Table Pfizer Production, Value, Price, Gross Margin 2015-2020
Table Celgene Profile
Table Celgene Production, Value, Price, Gross Margin 2015-2020
Table Genentech Profile
Table Genentech Production, Value, Price, Gross Margin 2015-2020
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
Table QIAGEN NV Profile
Table QIAGEN NV Production, Value, Price, Gross Margin 2015-2020
Table AstraZeneca Profile
Table AstraZeneca Production, Value, Price, Gross Margin 2015-2020
Table Roche Profile
Table Roche Production, Value, Price, Gross Margin 2015-2020
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020
Table OSI Pharmaceuticals Profile
Table OSI Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Table Novartis Profile
Table Novartis Production, Value, Price, Gross Margin 2015-2020
Figure Global NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Global NSCLS Drugs Revenue ($) and Growth (2015-2020)
Table Global NSCLS Drugs Sales by Regions (2015-2020)
Table Global NSCLS Drugs Sales Market Share by Regions (2015-2020)
Table Global NSCLS Drugs Revenue ($) by Regions (2015-2020)
Table Global NSCLS Drugs Revenue Market Share by Regions (2015-2020)
Table Global NSCLS Drugs Revenue Market Share by Regions in 2015
Table Global NSCLS Drugs Revenue Market Share by Regions in 2019
Figure North America NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Europe NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Asia-Pacific NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Middle East and Africa NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure South America NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure North America NSCLS Drugs Revenue ($) and Growth (2015-2020)
Table North America NSCLS Drugs Sales by Countries (2015-2020)
Table North America NSCLS Drugs Sales Market Share by Countries (2015-2020)
Figure North America NSCLS Drugs Sales Market Share by Countries in 2015
Figure North America NSCLS Drugs Sales Market Share by Countries in 2019
Table North America NSCLS Drugs Revenue ($) by Countries (2015-2020)
Table North America NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure North America NSCLS Drugs Revenue Market Share by Countries in 2015
Figure North America NSCLS Drugs Revenue Market Share by Countries in 2019
Figure United States NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Canada NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Mexico NSCLS Drugs Sales and Growth (2015-2020)
Figure Europe NSCLS Drugs Revenue ($) Growth (2015-2020)
Table Europe NSCLS Drugs Sales by Countries (2015-2020)
Table Europe NSCLS Drugs Sales Market Share by Countries (2015-2020)
Figure Europe NSCLS Drugs Sales Market Share by Countries in 2015
Figure Europe NSCLS Drugs Sales Market Share by Countries in 2019
Table Europe NSCLS Drugs Revenue ($) by Countries (2015-2020)
Table Europe NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure Europe NSCLS Drugs Revenue Market Share by Countries in 2015
Figure Europe NSCLS Drugs Revenue Market Share by Countries in 2019
Figure Germany NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure UK NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure France NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Italy NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Spain NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Russia NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Asia-Pacific NSCLS Drugs Revenue ($) and Growth (2015-2020)
Table Asia-Pacific NSCLS Drugs Sales by Countries (2015-2020)
Table Asia-Pacific NSCLS Drugs Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific NSCLS Drugs Sales Market Share by Countries in 2015
Figure Asia-Pacific NSCLS Drugs Sales Market Share by Countries in 2019
Table Asia-Pacific NSCLS Drugs Revenue ($) by Countries (2015-2020)
Table Asia-Pacific NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific NSCLS Drugs Revenue Market Share by Countries in 2015
Figure Asia-Pacific NSCLS Drugs Revenue Market Share by Countries in 2019
Figure China NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Japan NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure South Korea NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Australia NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure India NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Southeast Asia NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Middle East and Africa NSCLS Drugs Revenue ($) and Growth (2015-2020)
Table Middle East and Africa NSCLS Drugs Sales by Countries (2015-2020)
Table Middle East and Africa NSCLS Drugs Sales Market Share by Countries (2015-2020)
Table Middle East and Africa NSCLS Drugs Revenue ($) by Countries (2015-2020)
Table Middle East and Africa NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa NSCLS Drugs Revenue Market Share by Countries in 2015
Figure Middle East and Africa NSCLS Drugs Revenue Market Share by Countries in 2019
Figure Saudi Arabia NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure UAE NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Egypt NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Nigeria NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure South Africa NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure South America NSCLS Drugs Revenue ($) and Growth (2015-2020)
Table South America NSCLS Drugs Sales by Countries (2015-2020)
Table South America NSCLS Drugs Sales Market Share by Countries (2015-2020)
Table South America NSCLS Drugs Revenue ($) by Countries (2015-2020)
Table South America NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure South America NSCLS Drugs Revenue Market Share by Countries in 2015
Figure South America NSCLS Drugs Revenue Market Share by Countries in 2019
Figure Brazil NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Argentina NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Columbia NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Chile NSCLS Drugs Sales and Growth Rate (2015-2020)
Table Global NSCLS Drugs Sales by Types (2015-2020)
Table Global NSCLS Drugs Sales Share by Types (2015-2020)
Table Global NSCLS Drugs Revenue ($) by Types (2015-2020)
Table Global NSCLS Drugs Revenue Share by Types (2015-2020)
Figure Global Erlotinib (Tarceva and others) Sales and Growth Rate (2015-2020)
Figure Global Erlotinib (Tarceva and others) Price (2015-2020)
Figure Global Afatinib (Gilotrif) Sales and Growth Rate (2015-2020)
Figure Global Afatinib (Gilotrif) Price (2015-2020)
Figure Global Gefitinib (Iressa) Sales and Growth Rate (2015-2020)
Figure Global Gefitinib (Iressa) Price (2015-2020)
Figure Global Bevacizumab (Avastin) Sales and Growth Rate (2015-2020)
Figure Global Bevacizumab (Avastin) Price (2015-2020)
Figure Global Crizotinib (Xalkori) Sales and Growth Rate (2015-2020)
Figure Global Crizotinib (Xalkori) Price (2015-2020)
Figure Global Ceritinib (Zykadia) Sales and Growth Rate (2015-2020)
Figure Global Ceritinib (Zykadia) Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global NSCLS Drugs Sales by Applications (2015-2020)
Table Global NSCLS Drugs Sales Share by Applications (2015-2020)
Figure Global Squamous Cell Carcinoma Sales and Growth Rate (2015-2020)
Figure Global Squamous Cell Carcinoma Revenue and Growth Rate (2015-2020)
Figure Global Large Cell Carcinoma Sales and Growth Rate (2015-2020)
Figure Global Large Cell Carcinoma Revenue and Growth Rate (2015-2020)
Figure Global Adenocarcinoma Sales and Growth Rate (2015-2020)
Figure Global Adenocarcinoma Revenue and Growth Rate (2015-2020)
Figure Global NSCLS Drugs Sales and Growth Rate (2020-2026)
Figure Global NSCLS Drugs Revenue ($) and Growth Rate (2020-2026)
Table Global NSCLS Drugs Sales Forecast by Regions (2020-2026)
Table Global NSCLS Drugs Revenue Forecast by Regions (2020-2026)
Figure North America NSCLS Drugs Sales Forecast (2020-2026)
Figure North America NSCLS Drugs Revenue Forecast (2020-2026)
Figure Europe NSCLS Drugs Sales Forecast (2020-2026)
Figure Europe NSCLS Drugs Revenue Forecast (2020-2026)
Figure Asia-Pacific NSCLS Drugs Sales Forecast (2020-2026)
Figure Asia-Pacific NSCLS Drugs Revenue Forecast (2020-2026)
Figure Middle East and Africa NSCLS Drugs Sales Forecast (2020-2026)
Figure Middle East and Africa NSCLS Drugs Revenue Forecast (2020-2026)
Figure South America NSCLS Drugs Sales Forecast (2020-2026)
Figure South America NSCLS Drugs Revenue Forecast (2020-2026)
Table Global NSCLS Drugs Sales Forecast by Types (2020-2026)
Table Global NSCLS Drugs Sales Market Share Forecast by Types (2020-2026)
Table Global NSCLS Drugs Revenue Forecast by Types (2020-2026)
Table Global NSCLS Drugs Revenue Market Share Forecast by Types (2020-2026)
Table Global NSCLS Drugs Sales Forecast by Applications (2020-2026)
Table Global NSCLS Drugs Sales Market Share Forecast by Applications (2020-2026)
Table Global NSCLS Drugs Revenue Forecast by Applications (2020-2026)
Table Global NSCLS Drugs Revenue Market Share Forecast by Applications (2020-2026)
Similar Reports
Online banking or internet banking is a service provided by retail bank, virtual bank (neo banks) or credit unions. Online banking provides the customers with a secure website through which they can conduct financial transactions. Recent trends show that, customers are keenly adopting on...
- Publish Date: July 31, 2017
- $5370
ATMs have evolved from just cash dispensing machines to multifunctional equipment that provide not only cash withdrawal facilities but offer currency conversions facilities, account information, deposits, transfers, bill payment, cash recycling among other services. The Asia-Pacific region is becoming increasingly characterized by technology-facilitated transactions. ...
- Publish Date: March 1, 2016
- $3390
The Global P2P Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the P2P industry. The report provides a basic overview of the industry including definitions and classifications. The P2P market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...
- Publish Date: January 15, 2016
- $2800
